Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies
Clinical trial NCT02812056 · WITHDRAWN
Trial details
- NCT number
- NCT02812056
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2021-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.